A new AI program developed at Cedars‑Sinai’s Smidt Heart Institute can detect early signs of tricuspid valve disease through routine echocardiograms, with accuracy on par with expert cardiologists. Trained on over 47,000 echo scans from 2011 to 2021, it can now classify disease severity from mild to severe. This advancement could help clinicians spot and treat valve problems earlier, giving patients a better shot at timely care and improved outcomes.
News
